Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82,773,190
-
Total 13F shares
-
44,017,732
-
Share change
-
-6,930,754
-
Total reported value
-
$51,056,496
-
Put/Call ratio
-
73%
-
Price per share
-
$1.16
-
Number of holders
-
189
-
Value change
-
-$8,643,822
-
Number of buys
-
66
-
Number of sells
-
92
Institutional Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q1 2025
As of 31 Mar 2025,
Editas Medicine, Inc. - Common Stock (EDIT) was held by
189 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,017,732 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., MORGAN STANLEY, UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, BANK OF AMERICA CORP /DE/, TWO SIGMA INVESTMENTS, LP, and UBS Group AG.
This page lists
190
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.